
Omnicell, Inc.
OMCL
Updated: 23/09/2026, 08:04:17
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
No summaries found.
- Share price
- $33.17
- Market cap
- $1.51B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- Randall A. Lipps
- Employees
- 3,485
- IPO date
- 07/08/2001
- Beta
- 0.972
- Last dividend
- $0.00
- Day range
- $32.75 – $33.43
- 52-week range
- $29.06 – $55.00
- 1-day performance
- 2.28%
- 1-year performance
- 14.14%
- Current drawdown (1Y)
- -39.69%
- CIK
- 0000926326
- CUSIP
- 68213N109
- ISIN
- US68213N1090
- Created
- 07/12/2025, 05:36:07
- Last update
- 23/09/2026, 08:04:17
Track Omnicell, Inc. with an AI analyst
See which prediction-market events move OMCL, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Zacks Investment Research • STOCK • 10/06/2026, 14:41:11
Omnicell, Inc. (OMCL) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha • STOCK • 09/06/2026, 19:32:11
Omnicell: Why I'm Long Into Q2 Earnings Despite The Bookings Wobble
Seeking Alpha • STOCK • 09/06/2026, 10:10:34
Wall Street Analysts Predict a 40.57% Upside in Omnicell (OMCL): Here's What You Should Know
Zacks Investment Research • STOCK • 05/06/2026, 12:57:14
Omnicell (OMCL) is a Top-Ranked Momentum Stock: Should You Buy?
Zacks Investment Research • STOCK • 05/06/2026, 12:51:17
Is Omnicell Stock a Smart Addition to Your Portfolio Now?
Zacks Investment Research • STOCK • 04/06/2026, 13:02:09
Omnicell (OMCL) Up 0.1% Since Last Earnings Report: Can It Continue?
Zacks Investment Research • STOCK • 28/05/2026, 14:36:33
Omnicell Stock Surges 57.3% in a Year: What's Driving It?
Zacks Investment Research • STOCK • 25/05/2026, 12:06:08
How Much Upside is Left in Omnicell (OMCL)? Wall Street Analysts Think 39.87%
Zacks Investment Research • STOCK • 20/05/2026, 12:55:19
Omnicell, Inc. (OMCL) Shareholder/Analyst Call Prepared Remarks Transcript
Seeking Alpha • STOCK • 19/05/2026, 20:00:44
Omnicell, Inc. (OMCL) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Seeking Alpha • STOCK • 12/05/2026, 18:21:15
Here's Why Omnicell (OMCL) is a Strong Momentum Stock
Zacks Investment Research • STOCK • 07/05/2026, 12:50:22